BR0016092A - Compound, use of a compound kit for hormonal contraception in a male, and method of treatment - Google Patents

Compound, use of a compound kit for hormonal contraception in a male, and method of treatment

Info

Publication number
BR0016092A
BR0016092A BR0016092-0A BR0016092A BR0016092A BR 0016092 A BR0016092 A BR 0016092A BR 0016092 A BR0016092 A BR 0016092A BR 0016092 A BR0016092 A BR 0016092A
Authority
BR
Brazil
Prior art keywords
compound
male
treatment
kit
hormonal contraception
Prior art date
Application number
BR0016092-0A
Other languages
Portuguese (pt)
Inventor
Dirk Leysen
Jaap Van Der Louw
Roberta Buma Bursi
Marcel Evert De Gooyer
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Priority claimed from PCT/EP2000/012009 external-priority patent/WO2001040255A2/en
Publication of BR0016092A publication Critical patent/BR0016092A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Abstract

"COMPOSTO, USO DE UM COMPOSTO KIT PARA CONTRACEPçãO HORMONAL EM UM MACHO, E, MéTODO DE TRATAMENTO". A invenção descrita refere-se à verificação inesperada de esteróides inéditos que são caracterizados por um anel 14<225>-15<225>-ciclopropano e um grupo hidroximetila em 17<244>. Verificou-se que estes esteróides de acordo com a invenção têm em comum uma atividade androgênica. Eles podem ser usados para a preparação de um agente para contracepção masculina, e também para a preparação de um medicamento para o tratamento de insuficiência de androgênio."COMPOUND, USE OF A COMPOUND KIT FOR HORMONAL CONTRACEPTION IN A MALE, AND, TREATMENT METHOD". The invention described relates to the unexpected verification of unpublished steroids that are characterized by a 14 <225> -15 <225> -cyclopropane ring and a hydroxymethyl group at 17 <244>. These steroids according to the invention have been found to have an androgenic activity in common. They can be used for the preparation of an agent for male contraception, and also for the preparation of a drug for the treatment of androgen insufficiency.

BR0016092-0A 1999-12-02 2000-11-29 Compound, use of a compound kit for hormonal contraception in a male, and method of treatment BR0016092A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL99204080 1999-12-02
PCT/EP2000/012009 WO2001040255A2 (en) 1999-12-02 2000-11-29 14,15-beta-methylene substituted androgens

Publications (1)

Publication Number Publication Date
BR0016092A true BR0016092A (en) 2002-07-30

Family

ID=19877249

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016092-0A BR0016092A (en) 1999-12-02 2000-11-29 Compound, use of a compound kit for hormonal contraception in a male, and method of treatment

Country Status (2)

Country Link
KR (1) KR100730010B1 (en)
BR (1) BR0016092A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3086027A (en) 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
DE19537626A1 (en) * 1995-10-10 1997-04-17 Jenapharm Gmbh Steroids with a 14, 15 methylene group

Also Published As

Publication number Publication date
KR100730010B1 (en) 2007-06-20
KR20030024658A (en) 2003-03-26

Similar Documents

Publication Publication Date Title
GT199700009AA (en) COMBINED THERAPY FOR OSTEOPOROSIS
CR7420A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ONE OR VARIOUS STEROIDS, ONE OR VARIOUS COMPONENTS OF TETRAHIIDROPHOLATES AND VITAMIN B12
BR9404330A (en) Device for mixing a pharmaceutical composition with another agent, process for preparing a pharmaceutical preparation by mixing a pharmaceutical composition with an agent, and process for the oral application of a pharmaceutical preparation.
HUP0104718A3 (en) Micronized eplerenone compositions, process for their preparation and use thereof for the preparation of pharmaceutical compositions
ES2157447T3 (en) VACCINE COMPOSITION THAT INCLUDES A CONJUGATED POLYACARIDE ANTIGEN ADSORBED IN ALUMINUM PHOSPHATE.
BR0107667A (en) Crystal linezolid compound which is pharmaceutically useful as an antibacterial agent and method of preparing it
KR970706001A (en) PROCESS OF MAKING DOSAGE UNITS BY WET GRANULATION BY WET-GRANULATION
FI970526A7 (en) Estra-1,3,5(10)-triene derivatives, methods for their preparation and pharmaceutical compositions containing these compounds
ZA959729B (en) Immunogenic compositions
NO20003674L (en) Solid pharmaceutical preparations containing spleen phosin for oral administration in the treatment of Leishmaniase
WO2001040255A3 (en) 14,15-beta-methylene substituted androgens
HUP0203429A3 (en) Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone, process for their preparation and pharmaceutical compositions containing them
BR0010983A (en) Preparations for the application of anti-inflammatory agents
BR9915215A (en) Pharmaceutical composition for modified insulin sensitizer release
EA200100674A1 (en) CLEDRATES DEHYDROEPIANDROSTERONE AND RELATED PHARMACEUTICAL COMPOSITIONS
BR0005392A (en) Dhea composition and process
BR0016092A (en) Compound, use of a compound kit for hormonal contraception in a male, and method of treatment
DE69407057D1 (en) 1,3.5 (10) - ESTRATRIA DERIVATIVES WITH ORAL EFFECT
TR200200683T2 (en) Oral controlled release formulations.
AR003001A1 (en) PHARMACEUTICAL COMPOSITION STIMULATING OSTEOGENESIS.
BR9814136A (en) Contraceptive set, manufacturing processes and bleeding treatment, uses of anti-progestin, progestin and anti-progestin, and a compound.
BR0213466A (en) Use of (11beta, 17beta) -11- (1,3-benzodioxol-s-yl) -17-hydroxy-17- (1-propynyl) estra-4,9-dien-3-one, pharmaceutical preparation, and, Method for treating a patient suffering from severe depressive disorder
CL2023000450A1 (en) New composition of modified release oral contraceptive
WO2000067708A3 (en) Oral steroidal hormone compositions and methods of use
BR0113618A (en) 17-methylene steroids, processes for their preparation and pharmaceutical compositions containing these compounds

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 11A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2142 DE 24/01/2012.